The Dark Side of Good News in Biotech

Deal making is a staple of the biotech industry, but betting on mergers and acquisitions is much harder than it looks for investors.

from WSJ.com: Markets http://ift.tt/2tFDHmq
via https://ifttt.com/ IFTTT